CTCA is proud to share the expertise of our physicians through a series of free CME education, both virtual and live. Driven by the goal of improving patient care, our CME program is dedicated to providing a robust, well-rounded portfolio of CME activities that contribute to the greater good of our clinical communities.
This educational activity is designed to educate clinicians such as oncologists and gastroenterologists as well as physician-trainees, pharmacists, nurses and allied health professionals involved in the care and management of dysphagia, specifically for patients suffering from esophageal cancer. There are 1700 new cases per year in the U.S. which results in 1600 deaths. Those with esophageal cancer face a high mortality rate and ultimately their major goal is to prolong their life and improve their quality of life. Topics such as screening and diagnosis, managing comorbidities and treatment-related side effects, and palliative care will be covered for oncology specialists to expand their knowledge and transform their practice in cancer care.
Upon completion of this activity, participants will be able to:
Faculty:
Advancements in Cancer Management is an educational forum designed to foster dialogue between primary care providers (PCPs) and oncology teams to provide strategies that contribute to integrated cancer care for patients. Panel discussions, case studies and question-and-answer sessions will take place to enhance clinician knowledge and competence. Topics such as: screening high-risk patients, managing cancer pain, treating with immunotherapy and managing adverse events, monitoring for the long-term effects of treatment and/or disease, combining integrative therapies with cancer treatment, and addressing drug-drug interactions will be covered for PCPs to expand their knowledge and transform their practices in cancer care.
Upon completion of this activity, participants will be able to:
Faculty:
A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: squamous cell carcinoma of the scalp, papillary serous ovarian cancer, breast carcinoma and lung adenocarcinoma.
Upon completion of this activity, participants will be able to:
Faculty:
A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: breast cancer, large cell neuroendocrine carcinoma of the lung, sino-nasal undifferentiated carcinoma of the head & neck, and adenocarcinoma of the lung.
Upon completion of this activity, participants will be able to:
Faculty:
CHAT NOW